Fluid transport across human fetal membranes affected by human amniotic fluid prolactin: an in vitro study.
The aim of the study was to investigate the effects of human amniotic fluid (AF) prolactin (PRL) on the transfer of fluids across human fetal membranes, detected in vitro by weight change. We have developed a system, consisting of an inner compartment (4 ml), suspended in an outer compartment (40 ml), and separated from it by a 2 cm2 circular piece of fresh human fetal membrane (amnion, chorion and adhering decidua). The weight of the inner compartment was continuously registered with an electronic precision balance. Osmolality changes or hydrostatic pressure differences did not affect the rate of mass transfer through the membranes. Potassium cyanide significantly influenced the mass transfer in favour of the applied hydrostatic pressure difference (+2 cm H2O to the amniotic side) or osmotic pressure difference (amniotic side 265 mosm/kg/decidual side 285 mosm/kg). The PRL preparations used were human and ovine pituitary PRL, as well as three fractions isolated from human AF by fractionated ammonium sulphate and ethanol precipitations, followed by Sephacryl chromatography. All PRL preparations were tested in physiologic concentrations (0.5 to 5 micrograms/ml). Only the two largest AF-PRL variants significantly disturbed the balance of fluid transfer across the membranes when added to the fetal (amniotic) side of the membrane. This resulted in a net increase in fetomaternal transfer of 120 to 180 microliters. This effect could be repeated and lasted for at least 25 minutes. Using an antibody against hPRL the effect was completely blocked. Neither AF-PRL added to the maternal (decidual) side of the membrane nor oPRL or human pituitary PRL added to the amniotic or decidual side changed the rate of mass transfer across the membranes.
de Bakker-Teunissen
O J
OJ
Department of Obstetrics and Gynaecology, Free University Hospital, Amsterdam, The Netherlands.
Arts
N F
NF
Mulder
G H
GH
D000653:Amniotic Fluid / Q000032:analysis*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D005321:Extraembryonic Membranes / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D008722:Methods; D010902:Pituitary Gland / Q000032:analysis; D011247:Pregnancy; D011388:Prolactin / Q000032:analysis / Q000494:pharmacology*; D012756:Sheep; D014867:Water / Q000493:pharmacokinetics*
D014867:Water; D011388:Prolactin